Cryoballoon Catheter Ablation versus Antiarrhythmic Drug as a First-Line Therapy for Patients With Paroxysmal Atrial Fibrillation: Results of the Cryo-FIRST Study

Jean-Sylvain Hermida (1, 2) , Stewart Healey (3) , Giuseppe Arena (4) , Nicolas Badenco (5) , Christian Meyer (6) , Jian Chen (7) , Saverio Iacopino (8) , Frédéric Anselme (9) , Malte Kuniss (10) , Vedran Velagic (11) , Nikola Pavlovic (12) , Gian-Battista Chierchia (13)

1 CHU Amiens-Picardie
2 MP3CV - Mécanismes physiopathologiques et conséquences des calcifications vasculaires - UR UPJV 7517
3 Monash Health and Hudson Institute
4 University of Luxembourg [Luxembourg]
5 Institut de cardiologie [CHU Pitié-Salpêtrière]
6 University Heart Center [Hamburg]
7 OSU - Ohio State University [Columbus]
8 Maria Cecilia Hospital [Cotignola]
9 CHU Rouen
10 Kerckhoff-Klinik
11 University Hospital Centre Zagreb
12 University Hospital Sestre Milosrdnice
13 VUB - Vrije Universiteit Brussel

Domaines: Sciences du Vivant [q-bio]

Jean-Sylvain Hermida, Stewart Healey, Giuseppe Arena, Nicolas Badenco, Christian Meyer, et al.. Cryoballoon Catheter Ablation versus Antiarrhythmic Drug as a First-Line Therapy for Patients With Paroxysmal Atrial Fibrillation: Results of the Cryo-FIRST Study. Circulation, 2020, 142 (3). ⟨hal-03572222⟩